Evidence map›Paper›PMID 27147728›Full record

ReviewJournal of clinical microbiology2016

Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Matthew L Faron, Nathan A Ledeboer, Blake W Buchan

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 3 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 3 syntheses or guidelines pooled it, 227 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. A genomic snapshot of hospital-adapted CC17 vancomycin-resistant Enterococcus faecium colonising high-risk patients in Serbia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Article
  7. Investigating pathways of vancomycin-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Impact of stopping contact precautions onAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  14. Article
  15. Article
  16. Molecular Characterization of Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  17. Article
  18. bioRxiv : the preprint server for biology · 2025
    Article
  19. Evidence of vancomycin-resistantVeterinary world · 2025
    Article
  20. A successfully shortened outbreak of vancomycin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew L FaronMedical College of Wisconsin, Milwaukee, Wisconsin, USA.
Nathan A LedeboerMedical College of Wisconsin, Milwaukee, Wisconsin, USA Wisconsin Diagnostic Laboratories, Milwaukee, Wisconsin, USA.
Blake W BuchanMedical College of Wisconsin, Milwaukee, Wisconsin, USA Wisconsin Diagnostic Laboratories, Milwaukee, Wisconsin, USA bbuchan@mcw.edu.ORCID 0000-0002-4111-048X
Medical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections attributable to vancomycin-resistant Enterococcus (VRE) strains have become increasingly prevalent over the past decade. Prompt identification of colonized patients combined with effective multifaceted infection control practices can reduce the transmission of VRE and aid in the prevention of hospital-acquired infections (HAIs). Increasingly, the clinical microbiology laboratory is being asked to support infection control efforts through the early identification of potential patient or environmental reservoirs. This review discusses the factors that contribute to the rise of VRE as an important health care-associated pathogen, the utility of laboratory screening and various infection control strategies, and the available laboratory methods to identify VRE in clinical specimens.

Indexed as

Health FacilitiesCross InfectionDisease Transmission, InfectiousGram-Positive Bacterial InfectionsHumansInfection ControlMass ScreeningVancomycin-Resistant Enterococci

Identifiers

PMID27147728
PMCPMC5035425
OpenAlexW2346932889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.